Skip to main content
Premium Trial:

Request an Annual Quote

People in the News at 23andMe, DNAnexus, Next Gen Diagnostics, More

23andMe: Daniel Chu

23andMe has hired Daniel Chu as chief product officer. Chu comes to the genetic testing company after serving as chief product officer at Waymo, an Alphabet subsidiary that grew out of Google's self-driving car project. Prior to that, he led the product team for the Google Maps platform.

DNAnexus: Stephen Nuckols

DNAnexus has named Stephen Nuckols chief commercial officer to direct the company's growth strategy, sales, and marketing efforts following a $200 million financing round that closed earlier this year. Nuckols previously served as chief revenue officer of drug development software company ArisGlobal. Before ArisGlobal, he was executive VP and chief commercial officer of ERT, a clinical trial services firm that later merged with Bioclinica to form Clario.

Next Gen Diagnostics: Romney Humphries

Romney Humphries has joined the scientific advisory board of Next Gen Diagnostics. Humphries is the director of clinical microbiology at Vanderbilt University Medical Center and was a member of the scientific advisory board at Specific Diagnostics prior to it being sold to BioMérieux in May. Founded by members of the Sanger Institute, Next Gen Diagnostics offers pathogen bioinformatics products to enable the high-throughput clinical use of whole-genome sequencing. It also offers sequencing services for the detection of pathogen transmission in hospitals.

For additional recent items on executive appointments, promotions, and departures in the omics and molecular diagnostics space, please see the People in the News page on our website.

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.